NCT05356923

Brief Summary

The investigators here propose to investigate the timing and pattern of myocardial fibrosis activity following acute myocardial infarction using hybrid 68Ga-FAPI positron emission tomography and cardiovascular magnetic resonance. The investigators hypothesise that peak fibrosis activity will occur within 2-4 weeks of acute myocardial infarction and will predict subsequent scar formation and cardiac remodelling. Simultaneously, matrix remodelling and fibrosis activity in aortic and coronary atheroma will be assessed enabling the exploration of the presence of unstable atheroma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 21, 2021

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

April 26, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 2, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

May 17, 2024

Status Verified

March 1, 2023

Enrollment Period

2.7 years

First QC Date

April 26, 2022

Last Update Submit

May 16, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Time of maximal fibrosis activity following myocardial infarction

    SUVmax and TBR of 68Ga-FAPI uptake within the infarct, border zone, and remote myocardium

    12 weeks

  • Whether fibrosis activity predicts myocardial scar volume and ventricular remodelling

    As measured by CMR 12 months following acute MI

    12 months

  • Fibrosis activity and myocardial remodelling within atherosclerotic plaque in patients with myocardial infarct

    SUVmax and TBR of 68Ga-FAPI uptake within areas of atherosclerotic plaque in the aorta and/or carotid arteries

    12 weeks

Study Arms (3)

Healthy volunteers

Age- and sex- matched to participants, those aged 50 or over without known heart disease. n=20

Radiation: 68Gallium FAPI PET/MR scan

Acute myocardial infarction - multi-timepoint imaging

Those aged 50 or over with recent myocardial infarction who will be imaged using PET/MR at 1,2,4, and 12 weeks post-MI. n=20

Radiation: 68Gallium FAPI PET/MR scan

Acute or chronic myocardial infarction - single timepoint imaging

Those aged 50 or over with recent (n=20) or prior established (\>24 months, n=20) myocardial infarction who will be imaged at a single timepoint (1,2,4, or 12 weeks post-MI for acute, at the time of enrolement to the study for chronic).

Radiation: 68Gallium FAPI PET/MR scan

Interventions

68Gallium FAPI PET/MR scan

Acute myocardial infarction - multi-timepoint imagingAcute or chronic myocardial infarction - single timepoint imagingHealthy volunteers

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy volunteer participants (cohort 1, n=20): those without significant or serious comordibity or known cardiac disease Participants with acute myocardial infarction (cohorts 2 and 3, n=40): ST-elevation myocardial infarction within 3 weeks of enrollment Participants with chronic myocardial infarction (n=20): ST-elevation myocardial infarction 24 months or more prior to enrollment

You may qualify if:

  • specific to cohort;
  • aged 50 years or older

You may not qualify if:

  • Claustrophobia
  • Inability to undergo MRI
  • eGFR \<30ml/min/1.73\^m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Infirmary of Edinburgh

Edinburgh, City Of Edinburgh, EH16 4SA, United Kingdom

Location

Related Publications (1)

  • Barton AK, Craig NJ, Loganath K, Joshi S, Tsampasian V, Mahendran M, Lenell J, Tzolos E, Singh T, Whittington B, Nash J, Williams MC, van Beek EJR, MacAskill MG, Berkeley B, Vezaides S, Brittan M, Baker AH, Sellers S, Fletcher A, Clark T, Waight C, Slart RHJA, Berman D, Dey D, Slomka P, Newby DE, Dweck MR. Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study. J Am Coll Cardiol. 2025 Feb 18;85(6):578-591. doi: 10.1016/j.jacc.2024.10.103. Epub 2025 Jan 8.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood draw for all participants with recent or prior established myocardial infarction at each attendance for PET/MR scanning

MeSH Terms

Conditions

Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2022

First Posted

May 2, 2022

Study Start

April 21, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

May 17, 2024

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations